SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-21-001569
Filing Date
2021-08-26
Accepted
2021-08-26 07:45:49
Documents
14
Period of Report
2021-08-26
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tcrr-20210826.htm   iXBRL 8-K 48051
2 EX-99.1 tcrr-20210826ex99_1.htm EX-99.1 23217
3 GRAPHIC img11501727_0.jpg GRAPHIC 19431
  Complete submission text file 0000950170-21-001569.txt   226164

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tcrr-20210826_lab.xml EX-101.LAB 14046
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tcrr-20210826.xsd EX-101.SCH 2429
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tcrr-20210826_pre.xml EX-101.PRE 10372
7 EXTRACTED XBRL INSTANCE DOCUMENT tcrr-20210826_htm.xml XML 4881
Mailing Address 100 BINNEY STREET CAMBRIDGE MA 02142
Business Address 100 BINNEY STREET CAMBRIDGE MA 02142 617-949-5200
TCR2 THERAPEUTICS INC. (Filer) CIK: 0001750019 (see all company filings)

IRS No.: 474152751 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38811 | Film No.: 211208850
SIC: 2836 Biological Products, (No Diagnostic Substances)